Liu, Peng
Ji, Yaoting
Yuen, Tony
Rendina-Ruedy, Elizabeth
DeMambro, Victoria E.
Dhawan, Samarth
Abu-Amer, Wahid
Izadmehr, Sudeh
Zhou, Bin
Shin, Andrew C.
Latif, Rauf
Thangeswaran, Priyanthan
Gupta, Animesh
Li, Jianhua
Shnayder, Valeria
Robinson, Samuel T.
Yu, Yue Eric
Zhang, Xingjian
Yang, Feiran
Lu, Ping
Zhou, Yu
Zhu, Ling-Ling
Oberlin, Douglas J.
Davies, Terry F.
Reagan, Michaela R.
Brown, Aaron
Kumar, T. Rajendra
Epstein, Solomon
Iqbal, Jameel
Avadhani, Narayan G.
New, Maria I.
Molina, Henrik
van Klinken, Jan B.
Guo, Edward X.
Buettner, Christoph
Haider, Shozeb
Bian, Zhuan
Sun, Li
Rosen, Clifford J.
Zaidi, Mone
Article History
Received: 30 June 2016
Accepted: 5 April 2017
First Online: 24 May 2017
Competing interests
: Icahn School of Medicine at Mount Sinai has filed a provisional patent application that covers the application of FSH inhibition to decrease body fat (Provisional US Patent # 62/368,651). M.Z. is listed as inventor. M.Z. will receive royalties and/or licensing fees, according to Mount Sinai policies, if the aforementioned patent is commercialized. M.Z. also consults for Merck, Roche, Novartis, and a number of financial consulting platforms.